Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...
Hosted on MSN1mon
Ozempic-like jab 'fails' for millions with condition, study findsExperts had hoped a medication called exenatide, a weight loss jab in the same class of drugs as Ozempic and Wegovy, could help combat the degenerative nerve condition. But University College of ...
Hosted on MSN1mon
Study Finds Exenatide Not Beneficial for Parkinson DiseaseFRIDAY, Feb. 7, 2025 (HealthDay News) -- The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, according to a study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback